ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

TTOO T2 Biosystems Inc

5,40
-0,23 (-4,09%)
Zuletzt aktualisiert: 18:40:29
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
T2 Biosystems Inc TTOO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,23 -4,09% 5,40 18:40:29
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,55 5,30 5,68 5,63
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.5.202422:49EDGAR2Form 8-K - Current report
22.5.202415:00GLOBET2 Biosystems Regains Compliance with Nasdaq Continued..
20.5.202413:00EDGAR2Form 8-K - Current report
17.5.202422:05GLOBET2 Biosystems Announces Closing of $8 Million Private..
15.5.202413:00GLOBET2 Biosystems Announces $8 Million Private Placement Priced..
14.5.202423:00GLOBET2 Biosystems Announces CRG’s Conversion from Preferred..
14.5.202422:55EDGAR2Form RW - Registration Withdrawal Request
14.5.202422:43EDGAR2Form 8-K - Current report
14.5.202401:21EDGAR2Form SC 13D/A - General statement of acquisition of..
14.5.202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.5.202401:46EDGAR2Form SC 13D/A - General statement of acquisition of..
07.5.202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.5.202422:48EDGAR2Form 8-K - Current report
07.5.202415:00GLOBET2 Biosystems Announces Letter of Intent to Enter Strategic..
06.5.202423:27EDGAR2Form S-1/A - General form for registration of securities..
06.5.202423:24EDGAR2Form 8-K - Current report
06.5.202423:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.5.202422:34GLOBET2 Biosystems Announces First Quarter 2024 Financial Results
06.5.202422:34GLOBET2 Biosystems Announces Commercial Expansion Through Middle..
06.5.202422:29GLOBET2 Biosystems Announces the Conversion of an Additional $15..
06.5.202413:48EDGAR2Form S-1/A - General form for registration of securities..
24.4.202415:00GLOBET2 Biosystems to Report First Quarter 2024 Financial Results..
11.4.202422:05GLOBET2 Biosystems Shareholders Vote for CRG Debt Conversion into..
28.3.202414:00GLOBET2 Biosystems Announces Extension of Multi-Year Capital..
20.3.202412:30GLOBET2 Biosystems Unveils T2Lyme Launch Plans and Provides..
19.3.202414:00GLOBET2 Biosystems to Host Investor Call on March 20, 2024 to..
18.3.202414:00GLOBET2 Biosystems Announces New Publication Highlighting the..
12.3.202414:00GLOBET2 Biosystems Receives Extension to Comply with Nasdaq..
04.3.202422:34EDGAR2Form DEF 14A - Other definitive proxy statements
27.2.202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00EDGAR2Form 8-K - Current report
15.2.202422:49EDGAR2Form PRE 14A - Other preliminary proxy statements
15.2.202422:47EDGAR2Form 8-K - Current report
15.2.202422:06GLOBET2 Biosystems Announces Preliminary Fourth Quarter and Full..
15.2.202422:04GLOBET2 Biosystems Announces Agreement with CRG for the..
15.2.202422:02GLOBET2 Biosystems Announces Commercial Expansion Through..
14.2.202402:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202415:00GLOBET2 Biosystems Receives FDA 510(k) Clearance for the Expanded..
07.2.202422:05GLOBET2 Biosystems to Report Fourth Quarter and Full Year 2023..
18.1.202415:00GLOBET2 Biosystems Announces Participation in NIH-funded..
05.1.202422:00EDGAR2Form 8-K - Current report
03.1.202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202415:00GLOBET2 Biosystems Announces FDA 510(k) Submission to Expand Use..